Key result
Tranexamic acid for surgical bleeding requires an adequately powered randomized controlled trial to resolve uncertainty over vascular occlusive events.
Key points are not available for this paper at this time.
Uncertainty over vascular occlusive events warrants an adequately powered RCT
No takes yet. Share an insight, caveat, or question.
Ker et al. (2014) studied this question. Tranexamic acid for surgical bleeding requires an adequately powered randomized controlled trial to resolve uncertainty over vascular occlusive events.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: